Meta-Analyses Argue for Broader Use of SGLT2 Inhibitors in Chronic Kidney Disease

MedPage Today) — HOUSTON — SGLT2 inhibitors may hold a benefit for a wider pool of patients with chronic kidney disease (CKD) than previously thought, a pair of meta-analyses indicated.
SGLT2 inhibitors helped to slow the progression of CKD…